Skip to main content
NIH funding notice PAR-13-282

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21)

Closed on September 7, 2016.

Posted
July 24, 2013
Close date
September 7, 2016
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,722,432 in first-year total cost, median $234,000.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 SBIB-W (59)]4
  2. Clinical Molecular Imaging and Probe Development[CMIP]1
  3. Special Emphasis Panel[ZRG1 SBIB-D (59)]1
  4. Special Emphasis Panel[ZRG1 SBIB-Z (03)]1

Most frequent institutions

  1. EMORY UNIVERSITY2
  2. MCLEAN HOSPITAL1
  3. UNIVERSITY OF ALABAMA AT BIRMINGHAM1
  4. UNIVERSITY OF CALIFORNIA LOS ANGELES1
  5. UNIVERSITY OF CALIFORNIA-IRVINE1
Competing awards under PAR-13-282 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2017Nonhuman Primate CNS Assessments of 18F-Insulin After Intranasal Administration1R21AG054960-01GERDES, JOHN MKESSLER, ROBERT MICHAELZINN, KURT RUNIVERSITY OF ALABAMA AT BIRMINGHAM, AL$316,613ZRG1
2016PET Imaging Agents for 5-HT2C Receptors1R21MH108928-01GOODMAN, MARK MYRONEMORY UNIVERSITY, GA$234,000ZRG1
2015TrkB Receptor PET Tracer Development1R21AG050793-01STEHOUWER, JEFFREY SCOTTYE, KEQIANGEMORY UNIVERSITY, GA$234,000ZRG1
2015Fluorine-18 Labeled Functional Dopamine Receptor Imaging Agents1R21DA038866-01A1MUKHERJEE, JOGESHWARUNIVERSITY OF CALIFORNIA-IRVINE, CA$231,750ZRG1
2015Automated microfluidic production of high specific activity PET tracers to enable routine CNS imaging1R21AG049918-01VAN DAM, ROBERT MICHAELUNIVERSITY OF CALIFORNIA LOS ANGELES, CA$231,000ZRG1
2015Radioligands for Sigma-2 Receptor Studies in the CNS by PET1R21DA039818-01A1LEVER, SUSAN ZUNIVERSITY OF MISSOURI-COLUMBIA, MO$214,611ZRG1
2014F_18 Labeled D2 Agonist Ligands for PET Imaging of Dopaminergic Dysfunction1R21MH103718-01A1SROMEK, ANNA WACLAWAMCLEAN HOSPITAL, MA$260,458CMIP

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-13-282: Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21) | ScienceDex | ConductScience